mash and glp 1 Semaglutide Receives FDA Approval for Treatment of Efficacy and safety of GLP-1
Description
The side effect profiles differ
Most people lose 5-10% of their initial weight on these medications
Patients should remain vigilant for several days following a dosing error, monitoring both gastrointestinal symptoms and blood glucose levels if home monitoring equipment is available
Special cells called L-cells in your small intestine detect the presence of amino acids (proteins building blocks) and respond by releasing GLP-1 into your bloodstream
Discussion This retrospective study demonstrated that treatment with GLP-1 RAs has a beneficial impact on tear production and stability in patients with T2DM, potentially reducing the risk of developing dry eye disease
